RIDGEBACK CAPITAL

ridgeback-capital-logo

Ridgeback Capital is a private investment firm that focuses on private and public companies in the life sciences sector. The company was founded in 2006 by Dr. Holman and is headquartered in New York, NY.

#SimilarOrganizations #People #Financial #More

RIDGEBACK CAPITAL

Social Links:

Industry:
Biotechnology Finance Financial Services

Founded:
2006-01-01

Status:
Active

Contact:
212-624-2600

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta SPF Google Font API LetsEncrypt Content Delivery Network Domain Not Resolving Euro Organization Schema Person Schema COVID-19


Similar Organizations

casdin-capital-logo

Casdin Capital

Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry.

clarus-ventures-logo

Clarus Ventures

Clarus Ventures is a Massachusetts-based venture capital firm focused on investments in the healthcare sector.

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

Current Employees Featured

not_available_image

Leo Sternlicht
Leo Sternlicht Director @ Ridgeback Capital
Director
2010-10-01

not_available_image

Wayne Holman
Wayne Holman CEO @ Ridgeback Capital
CEO
2006-01-01

Founder


not_available_image

Wayne Holman

Investments List

Date Company Article Money raised
2022-02-02 Crisp Ridgeback Capital investment in Series B - Crisp 35 M USD
2021-12-07 Freenome Ridgeback Capital investment in Series D - Freenome 300 M USD
2021-11-29 Quell Therapeutics Ridgeback Capital investment in Series B - Quell Therapeutics 156 M USD
2021-11-09 Arbor Biotechnologies Ridgeback Capital investment in Series B - Arbor Biotechnologies 215 M USD
2021-09-23 Garuda Therapeutics Ridgeback Capital investment in Series A - Garuda Therapeutics 72 M USD
2021-07-14 Turnstone Biologics Ridgeback Capital investment in Series D - Turnstone Biologics 80 M USD
2021-05-06 TwinStrand Biosciences Ridgeback Capital investment in Series B - TwinStrand Biosciences 50 M USD
2021-03-30 Pyxis Oncology Ridgeback Capital investment in Series B - Pyxis Oncology 152 M USD
2021-03-16 Acepodia Ridgeback Capital investment in Series B - Acepodia 47 M USD
2021-03-03 Caribou Biosciences Ridgeback Capital investment in Series C - Caribou Biosciences 115 M USD

More informations about "Ridgeback Capital" on Search Engine